Evidence map›Paper›PMID 38400905›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

A proactive financial navigation intervention in patients with newly diagnosed gastric and gastroesophageal junction adenocarcinoma.

Ari Bell-Brown, Talor Hopkins, Kate Watabayashi, Karen Overstreet, Anthony Leahy, Erin Bradshaw, Kathleen Gallagher, Jennifer Obenchain, Amber Padron, Beth Scott and 2 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03986502 (Pilot Randomized Study of a Proactive Financial Navigation Intervention in Patients With Newly Diagnosed Gastric and Gastroesophageal Junction), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
7.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03986502 nacompletednot on this map

Pilot Randomized Study of a Proactive Financial Navigation Intervention in Patients With Newly Diagnosed Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

TypeinterventionalSponsorFred Hutchinson Cancer CenterRan2021 to 2022Enrolled30ConditionsGastric Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaArmsMedia Intervention, Informational Intervention, Best Practice, Questionnaire Administration, Quality-of-Life Assessment
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ari Bell-BrownHutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, 1100 Fairview Ave N., Mailstop M3-B232, Seattle, WA, 98109, USA. abellbro@fredhutch.org.
Talor HopkinsHutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, 1100 Fairview Ave N., Mailstop M3-B232, Seattle, WA, 98109, USA.
Kate WatabayashiHutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, 1100 Fairview Ave N., Mailstop M3-B232, Seattle, WA, 98109, USA.
Karen OverstreetConsumer Education and Training Services, Seattle, WA, USA.
Anthony LeahyConsumer Education and Training Services, Seattle, WA, USA.
Erin BradshawPatient Advocate Foundation, Washington, DC, USA.
Kathleen GallagherPatient Advocate Foundation, Washington, DC, USA.
Jennifer ObenchainPatient Advocate Foundation, Washington, DC, USA.
Amber PadronPatient Advocate Foundation, Washington, DC, USA.
Beth ScottPatient Advocate Foundation, Washington, DC, USA.
Brooke FloresPatient Advocate Foundation, Washington, DC, USA.
Veena ShankaranHutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, 1100 Fairview Ave N., Mailstop M3-B232, Seattle, WA, 98109, USA.
Patient Advocate Foundation · USFred Hutch Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMany cancer patients and caregivers experience financial hardship, leading to poor outcomes. Gastric and gastroesophageal junction (GEJ) cancer patients are particularly at risk for financial hardship given the intensity of treatment. This pilot randomized study among gastric/GEJ cancer patients and caregivers tested a proactive financial navigation (FN) intervention to obtain a signal of efficacy to inform a larger, more rigorous randomized study.

methodsWe tested a 3-month proactive FN intervention among gastric/GEJ cancer patients and caregivers compared to usual care. Caregiver participation was optional. The primary endpoint was incidence of financial hardship, defined as follows: accrual of debt, income decline of ≥ 20%, or taking loans to pay for treatment. Data from participant surveys and documentation by partner organizations delivering the FN intervention was analyzed and outcomes were compared between study arms.

resultsNineteen patients and 12 caregivers consented. Primary FN resources provided included insurance navigation, budget planning, and help with out-of-pocket medical expenses. Usual care patients were more likely to experience financial hardship (50% vs 40%) and declines in quality of life (37.5% vs 0%) compared to intervention patients. Caregivers in both arms reported increased financial stress and poorer quality of life over the study period.

conclusionsProactive financial navigation has potentially positive impacts on financial hardship and quality of life for cancer patients and more large-scale randomized interventions should be conducted to rigorously explore the impact of similar interventions. Interventions that have the potential to lessen caregiver financial stress and burden need further exploration.

trial registrationTRN: NCT03986502, June 14, 2019.

Indexed as

AdenocarcinomaEsophageal NeoplasmsQuality of LifeEsophagogastric JunctionHumansIncomeFinancial hardshipFinancial navigationGastric cancerGastroesophageal junction cancer

Identifiers

PMID38400905
PMCPMC10894103
OpenAlexW4392131932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.